Table 2 cost-effectiveness comparison
Utility(QALY) | Increased utility | Cost($) | Increased costs | ICER | |
|---|---|---|---|---|---|
warfarin | 11.07 | 5317.31 | |||
Rivaroxaban | 15.46 | 4.39 | 29673.33 | 24356.02 | 5548.07 |
Dabigatran110mg | 12.40 | 1.33 | 23615.48 | 18298.17 | 13758.02 |
Dabigatran150mg | 15.00 | 3.93 | 34324.91 | 29007.60 | 7381.07 |